Keogh Institute for Medical Research Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2005
NCT00809068
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (4)

fenofibrate (fenoglide) (1 trial)

fish oil (Omegavan) (1 trial)

olive oil (1 trial)

xyvion (1 trial)

Drugs in Other Trials (2)

alprostadil (prostin) (1 trial)

sildenafil (viagra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Polycystic Ovary Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6